Therapeutic Asset Ratings
461 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
pf-07820435
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-07820435
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07826390
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-07826390
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07934040
Pancreatic Ductal Adenocarcinoma
Pfizer
P1
CC
(43)
pf-07985045
Pancreatic Ductal Adenocarcinoma
Pfizer
P1
CC
(43)
pf-08046033
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-08046037
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-08046037
Pancreatic Ductal Adenocarcinoma
Pfizer
P1
CC
(43)
pf-08046037
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-08046876
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
Tucatinib
Gastroesophageal Adenocarcinoma
Pfizer
P1
CC
(43)
pf-08634404
Nonpapillary Renal Cell Carcinoma
Pfizer
P1/2
CC
(43)
Lotiglipron
Obesity Disorder
Pfizer
P2
CC
(42)
Binimetinib
Thyroid Cancer
Pfizer
P1
CC
(41)
Claturafenib
Thyroid Cancer
Pfizer
P1
CC
(41)
Eloxatin
Thyroid Cancer
Pfizer
P1
CC
(41)
Enzalutamide
Follicular Lymphoma
Pfizer
P1
CC
(41)
FULVESTRANT
Colorectal Adenocarcinoma
Pfizer
P1
CC
(41)
Itraconazole
Small Cell Lung Carcinoma
Pfizer
P1
CC
(41)
Mevrometostat
Follicular Lymphoma
Pfizer
P1
CC
(41)
Mevrometostat
Small Cell Lung Carcinoma
Pfizer
P1
CC
(41)
MIDAZOLAM
Thyroid Cancer
Pfizer
P1
CC
(41)
pf-07260437
Endometrial Cancer
Pfizer
P1
CC
(41)
pf-07263689
Squamous Cell Carcinoma
Pfizer
P1
CC
(41)
Showing 301 to 325 of 461 assets
Previous
Page 13 of 19
Next
